Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 804 across all filing types
Latest filing 2024-04-29 Interim / Quarterly Rep…
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
Konsolidirani financijski izvještaji Grupa Medika d.d. 31.03.2024..pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Međuinvještaj poslovodstva' (Management Interim Report) for the first quarter of 2024 (I-III 2024) for Medika Group. It contains detailed financial analysis, balance sheet data, income statement highlights, and management commentary on business performance, risks, and outlook. It is a comprehensive quarterly financial report, not an announcement or a summary, and it includes substantive financial data. Q1 2024
2024-04-29 Croatian
tfi-pod-eur-Medika-hrv.xlsx
Financial Supplement Data
2024-04-29 Croatian
Financijski izvještaji Medika d.d. 31.03.2024..pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Međuinvještaj poslovodstva' (Management Interim Report) for Medika d.d. covering the first quarter (I-III) of 2024. It contains detailed financial analysis, business performance commentary, balance sheet data, and risk assessments for the specified period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2024
2024-04-29 Croatian
Održana sjednica Uprave 29.04.2024.pdf
AGM Information Classification · 99% confidence The document is a short announcement dated April 29, 2024, from MEDIKA d.d. It explicitly states that the Management Board (Uprava) adopted the non-consolidated and consolidated financial statements for the period 01.01.-31.03.2024. It further mentions that these statements will be reviewed by the Supervisory Board on May 2, 2024. Since the document itself is an announcement about the adoption of financial reports for a specific period (Q1 2024) and is very short, it functions as a notification that financial results have been prepared and approved internally, but it is not the full report itself. This fits the description of an Earnings Release (ER) which is the initial announcement of periodical financial results (key highlights only), or potentially a Report Publication Announcement (RPA) if it were only announcing the *future* release. Given that it announces the *adoption* of the Q1 2024 results, ER is the most appropriate fit for announcing the period's performance summary, even if the full details are pending board review.
2024-04-29 Croatian
Najava sjednice Uprave 29.04.2024. i sjednice NO 02.05.2024.pdf
Report Publication Announcement Classification · 99% confidence The document is a short announcement from MEDIKA d.d. dated April 24, 2024. The subject is 'NAJAVA SJEDNICE UPRAVE I SJEDNICE NADZORNOG ODBORA DRUŠTVA' (Announcement of Management Board Meeting and Supervisory Board Meeting). The key agenda items listed for these meetings are the review of financial reports for the period 01.01.-31.03.2024 (Q1 2024). Since this document is an announcement about upcoming board meetings where financial results will be discussed/approved, and it is very short (951 chars), it is not the financial report itself (like IR or ER). It is an announcement regarding corporate governance/board activity, but more specifically, it is announcing the process leading up to the release of financial information. Given the options, this is a general regulatory announcement concerning internal corporate events, which often falls under Regulatory Filings (RNS) if no other specific category fits perfectly. However, since it announces the review of financial reports (Q1 2024), it is closely related to the upcoming Earnings Release (ER) or Interim Report (IR). Since it is only announcing the *meeting* where these will be discussed, and not the results themselves, the most appropriate general category for an announcement of internal corporate proceedings that doesn't fit MANG (Board Change) or DIV/CAP is RNS. If the document were announcing the *release* of the Q1 results, it would be ER. As it is announcing the *meeting* to discuss them, RNS is the safest fit among the provided codes, as it is a general regulatory disclosure about internal corporate scheduling.
2024-04-24 Croatian
tfi-pod_Grupa Medika_30092022.xlsx
Financial Supplement Data
2022-10-27 Croatian

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.